Perfectha Website AW EB2

PERFECTION JUST GOT EVEN BETTER

Introducing
Perfectha Lidocaine
Not an actual patient.

Sinclair Pharma, has been commited to skin expertise since 1971,
and more recently to the development of a safe, minimally invasive and effective portfolio of aesthetic treatments including Perfectha.

Sinclair Pharma Deutschland ׀ College Banner

MADE IN FRANCE
by Sinclair

Perfectha is manufactured 100% in France by Sinclair France SAS in its laboratory specialised in the research, development and manufacturing of Hyaluronic Acid (HA) fillers, and ISO 13485 certified since 2007.

Read up on Perfectha with our Physician brochure

The biocompatibility and performance of the entire Perfectha range have been clinically demonstrated. Perfectha complies with all safety standards required by health authorities and has been CE marked since 2007. Perfectha is registered and launched in more than 70 countries around the world. With more than 13 years of clinical use, 3.3 million syringes sold worldwide, Perfectha has established itself among the leaders on the aesthetic market.

Particles

Contact Us

Reach out to our brilliant teams and get started with Perfectha. Please include your country and postcode.

INDICATION

Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them.

INDICATION

Perfectha is a line of resorbable hyaluronic acid (HA) gel implants intended for reconstructive purposes in the treatment, for instance, of facial lipoatrophy, or morphological asymmetry associated with the aging process or other underlying conditions. Perfectha is for intradermal and subcutaneous application and is implanted in the areas of the face and hands to fill skin depressions and also for the augmentation of tissue volume.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Perfectha distributor. Alternatively send the details to Sinclair on: quality@sinclairpharma.com

For a full list of contraindications, warnings and precautions for this product please visit https://www.sinclairpharma.com/eifu for copy of the Product Instructions for Use.